When Should You SELL Your Stocks (8 Reasons to Sell Your Stocks) Click to watch on Youtube.

Fate Therapeutics Stock Forecast

NASDAQ:FATE BUY

$33.42 (2.67%)

Volume: 1.16M

Closed: Aug 05, 2022

Hollow Logo Score: 5.137

Fate Therapeutics Stock Forecast

BUY NASDAQ:FATE
$33.42 (2.67%)

Volume: 1.16M

Closed: Aug 05, 2022

Score Hollow Logo 5.137

Fate Therapeutics Stock Price (Quote) NASDAQ:FATE

$33.42 ( 2.67% ) Friday, 5th Aug 2022

Range Low Price High Price Comment
30 days $26.99 $36.00 Friday, 5th Aug 2022 FATE stock ended at $33.42. This is 2.67% more than the trading day before Thursday, 4th Aug 2022. During the day the stock fluctuated 10.16% from a day low at $30.70 to a day high of $33.82.
90 days $17.10 $36.00
52 weeks $17.10 $97.43

Historical Fate Therapeutics prices

Date Open High Low Close Volume
2022-08-05 $31.58 $33.82 $30.70 $33.42 1 159 549
2022-08-04 $33.66 $36.00 $29.76 $32.55 2 188 213
2022-08-03 $31.43 $34.39 $31.43 $32.81 1 487 267
2022-08-02 $29.59 $31.08 $29.51 $30.63 979 438
2022-08-01 $30.05 $31.77 $29.81 $30.04 886 415
2022-07-29 $31.57 $31.79 $30.37 $30.53 940 032
2022-07-28 $33.20 $34.01 $30.57 $32.15 880 131
2022-07-27 $31.96 $33.32 $31.16 $33.17 1 028 264
2022-07-26 $30.69 $32.26 $30.21 $31.38 768 737
2022-07-25 $31.04 $31.15 $29.73 $30.74 943 093
2022-07-22 $33.59 $33.84 $30.98 $31.04 1 277 315
2022-07-21 $32.52 $33.36 $31.82 $33.34 883 971
2022-07-20 $32.46 $34.55 $31.96 $32.64 1 639 063
2022-07-19 $31.25 $32.61 $30.18 $32.50 1 038 557
2022-07-18 $32.31 $33.23 $30.34 $30.68 971 712
2022-07-15 $32.42 $32.42 $30.01 $31.70 1 071 657
2022-07-14 $31.10 $32.03 $30.24 $31.51 972 701
2022-07-13 $28.81 $31.92 $28.73 $31.29 1 327 533
2022-07-12 $28.66 $29.91 $26.99 $29.78 1 425 572
2022-07-11 $30.34 $30.57 $28.34 $28.51 1 441 429
2022-07-08 $29.91 $31.07 $29.59 $30.01 1 819 995
2022-07-07 $28.58 $31.49 $28.04 $30.93 1 797 549
2022-07-06 $28.73 $30.23 $27.89 $28.63 1 924 217
2022-07-05 $24.93 $29.12 $24.30 $29.10 2 436 815
2022-07-01 $25.14 $25.45 $24.15 $25.14 1 082 033
2022-06-30 $24.35 $25.02 $23.50 $24.78 1 063 148
2022-06-29 $24.76 $25.29 $23.99 $24.88 1 005 609
2022-06-28 $26.26 $26.81 $24.55 $24.75 1 302 395
2022-06-27 $26.78 $26.95 $25.22 $26.25 1 655 178
2022-06-24 $26.02 $26.86 $24.52 $26.80 2 317 816
2022-06-23 $23.65 $25.66 $23.28 $25.61 1 559 946
2022-06-22 $21.55 $23.95 $21.37 $23.61 1 967 020
2022-06-21 $21.48 $23.03 $21.48 $22.23 2 166 690
2022-06-17 $19.77 $22.11 $19.55 $21.04 4 731 713
2022-06-16 $18.42 $19.65 $18.31 $19.36 1 980 163
2022-06-15 $18.97 $20.04 $18.64 $19.38 2 119 827
2022-06-14 $17.98 $18.66 $17.27 $18.63 1 580 310
2022-06-13 $18.71 $18.81 $17.10 $17.78 2 087 274
2022-06-10 $22.44 $22.53 $19.62 $19.81 2 133 202
2022-06-09 $24.00 $24.30 $23.12 $23.48 1 288 693
2022-06-08 $24.22 $25.10 $23.75 $24.26 1 657 893
2022-06-07 $21.61 $24.32 $21.49 $24.29 1 773 140
2022-06-06 $24.28 $24.90 $21.26 $22.00 2 084 296
2022-06-03 $22.53 $24.16 $22.41 $23.65 1 774 480
2022-06-02 $22.55 $23.66 $22.00 $23.31 686 102
2022-06-01 $22.96 $24.21 $22.39 $22.63 1 661 338
2022-05-31 $23.13 $23.66 $22.42 $23.10 2 149 611
2022-05-27 $22.50 $23.70 $21.60 $23.58 1 271 184
2022-05-26 $22.03 $22.87 $21.54 $22.43 1 255 596
2022-05-25 $21.05 $22.30 $21.05 $21.85 1 977 966

About Fate Therapeutics

Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat mul... Read more

.

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT